α-Galactosylceramide

  Cat. No.:  DC28134   Featured
Chemical Structure
158021-47-7
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor).
Cas No.: 158021-47-7
Chemical Name: α-Galactosylceramide
Synonyms: Hexacosanamide,N-[(1S,2S,3R)-1-[(a-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;α-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;alpha-Galactosylceramide;KRN 7000;N-[(2S,3S,4R)-3,4-dihydroxy-1-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadecan-2-yl]hexacosanamide;α-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;α1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine;AGL-582;Α-GALACTOSYL CERAMIDE;α-GalCer;(2S,3S,4R)-1-O-(α-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;N-[(1S,2S,3R)-1-[(α-D-Galactopyranosyloxy)Methyl]-2,3-dihydroxyheptadecyl]hexacosanaMide;KRN7000;α-Galactosyl CeraMide;α-Galactosylceramide;A-Galactosylceramide;AKOS040741093;HEXACOSANAMIDE, N-((1S,2S,3R)-1-((.ALPHA.-D-GALACTOPYRANOSYLOXY)METHYL)-2,3-DIHYDROXYHEPTADECYL)-;EX-A5755;N-((2S,3S,4R)-3,4-dihydroxy-1-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)octadecan-2-yl)hexacosanamide;Krn-7000;hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-;SCHEMBL512949;CHEBI:466659;N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE;RGI-7000;-GalCer;KRN7000;(2S,3S,4R)-1-O-(alpha-D-galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol;.alpha.-galcer;C16892;-Galactosylceramide;alpha-GalCer(t18:0/26:0);Hexacosanamide, N-[(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]- (9CI);Krn 7000;N-[(2S,3S,4R)-1-(alpha-D-galactopyranosyloxy)-3,4-dihydroxyoctadecan-2-yl]hexacosanamide;AC-31508;Q27105159;CHEMID158021477;GLXC-26234;Epitope ID:130694;RGI-2001;N-{(1S,2S,3R)-1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl}hexacosanamide;Galalpha-Cer(t18:0/26:0);UNII-WX671898JF;WX671898JF;A-Galactosyl Ceramide Supplier: Funakoshi Co. Ltd.;alpha-Galactosylceramide(a-Gal-Cer) (synthetic);1-O-(alpha-D-galactopyranosyl)-N-hexacosanoylphytosphingosine;Hexacosanamide, N-[1-[(alpha-D-galactopyranosyloxy)methyl]-2,3-dihydroxyheptadecyl]-, [1S-(1R*,2R*,3S*)]-;CCRIS 8968;(2S,3S,4R)-1-O-(alpha-D-Galactosyl)-N-hexacosanoyl-2-amino-1,3,4-octadecanetriol, >=95% (TLC);alpha-GalCer;CHEMBL384200;Hexacosanamide, N-(1-((alpha-D-galactopyranosyloxy)methyl)-2,3-dihdyroxyheptadecyl)-, (1S-(1R*,2R*,3S*))-;NS00073040;alpha-Galactosyl Ceramide;alpha-GC(C26);DTXSID40935847;MFCD00939559;VQFKFAKEUMHBLV-BYSUZVQFSA-N;??-Galactosylceramide;DB12232;158021-47-7;N-((2S,3S,4R)-3,4-dihydroxy-1-(3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)octadecan-2-yl)hexaicosanamide;alpha-GC (C26);(+)-KRN-7000
SMILES: CCCCCCCCCCCCCCCCCCCCCCCCCC(N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)=O
Formula: C50H99NO9
M.Wt: 858.32236
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
TITLE DOWNLOAD
MSDS_12189_DC28134_158021-47-7
COA
LOT NO. DOWNLOAD
Cat. No. Product name Field of application
DC28134 α-Galactosylceramide α-Galactosylceramide (α-GalCer) is a synthetic glycolipid with antitumorial and immunostimulatory. α-Galactosylceramide is a very potent NKT cell agonist and binds effectively to CD1d. The complex of α-Galactosylceramide plus CD1d binds the NKT cell TCR (T cell antigen receptor).
X